Harris A Gelbard

USPTO Granted Patents = 8 (Patent Applications = 3)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 29(Granted Patents)

Company Filing History:

6 out of 973

University of Rochester

University of Nebraska

where one patent can have more than one assignee

Years Active: 2014-2023

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11661409 - Acid addition salts, compositions, and methods of treating (2023-05-30),

2. 11479541 - Acid addition salts, compositions, and methods of treating thereof (2022-10-25),

3. 10485800 - Mixed lineage kinase inhibitors for HIV/AIDS therapies (2019-11-26),

4. 9814704 - Substituted pyrrolo[2,3-b]pyridines as MLK inhibitors (2017-11-14),

5. 9370515 - Mixed lineage kinase inhibitors and method of treatments (2016-06-21),

6. 9181247 - Substituted pyrrolo[2,3-B]pyridines as MLK inhibitors (2015-11-10),

7. 8877772 - Substituted pyrrolo[2,3-B]pyridines as MLK inhibitors (2014-11-04),

8. 8846909 - Bicyclic heteroaryl kinase inhibitors and methods of use (2014-09-30),

Title: The Innovative Contributions of Harris A Gelbard

Introduction

Harris A Gelbard is a distinguished inventor based in Pittsford, NY, recognized for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of eight patents, Gelbard's work primarily focuses on novel compositions and methods for treating diseases associated with neuroinflammation.

Latest Patents

Among his latest patents, Gelbard has developed innovative acid addition salts, notably the tartrate salt of 3-(1H-indol-5-yl)-5-[4-[(4-methyl-1-piperazinyl)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridine. This patent includes not only the crystalline forms of this compound but also pharmaceutical compositions that incorporate these salts alongside suitable excipients. The methods described offer therapeutic avenues for treating disorders linked to neuroinflammation through the administration of these effective acid addition salts or the corresponding pharmaceutical compositions.

Another significant patent includes a broader range of acid addition salts, such as phosphate and fumarate salts, maintaining a focus on therapeutic applications targeting neuroinflammatory diseases. The provided compositions demonstrate Gelbard's commitment to addressing critical health challenges using innovative chemical solutions.

Career Highlights

Harris A Gelbard's career is marked by notable associations with leading research institutions and companies. He has made substantial contributions while working at the University of Rochester and Pioneura Corporation. His roles have allowed him to push the boundaries of pharmaceutical science, particularly in the realm of drug development aimed at neuroinflammatory conditions.

Collaborations

Throughout his career, Gelbard has collaborated with esteemed colleagues such as Stephen Dewhurst and Val S Goodfellow. These partnerships have fostered a rich environment for innovation, leading to groundbreaking advancements in medical and pharmaceutical applications.

Conclusion

Harris A Gelbard exemplifies the spirit of innovation in the pharmaceutical industry. His extensive work on acid addition salts and their applications in treating neuroinflammatory disorders underscores his role as a leading inventor, contributing meaningful advancements to healthcare. His legacy continues to inspire future research and development in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.